CRSP Operating Income
Crispr Therapeutics Ag · Operating Income
CRSP Operating Income
Latest reported-$531.87Mperiod ending
CRSP TTM Operating Income (-$25.73M → -$531.87M)
TTM operating income
High-resolution chart · PNG
CRSP operating income history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Income (USD) |
|---|---|
| -531,867,000 | |
| -550,142,000 | |
| -568,318,000 | |
| -478,142,000 | |
| -456,213,000 | |
| -474,402,000 | |
| -466,565,000 | |
| -332,394,000 | |
| -354,675,000 | |
| -298,638,000 | |
| -222,538,000 | |
| -423,662,000 | |
| -473,639,000 | |
| -561,676,000 | |
| -673,161,000 | |
| -687,318,000 | |
| -633,779,000 | |
| 312,099,000 | |
| 373,528,000 | |
| 411,465,000 | |
| 447,915,000 | |
| -395,392,000 | |
| -354,435,000 | |
| -235,691,000 | |
| -4,129,000 | |
| 21,577,000 | |
| 46,740,000 | |
| -9,471,000 | |
| -198,066,000 | |
| -180,369,000 | |
| -158,943,000 | |
| -112,743,000 | |
| -86,881,000 | |
| -70,901,000 | |
| -64,648,000 | |
| -90,930,000 | |
| -81,970,000 | |
| -77,222,000 | |
| -68,130,000 | |
| -54,986,000 | |
| -46,578,000 | |
| -33,645,000 | |
| -25,729,000 |